The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior

Developmental Psychobiology

Volumn 50, Issue 7, 2008, Pages 680-689

  Sandman, Curt A ^a   Touchette, Paul E ^a   Marion, Sarah D ^b   Chicz DeMet, Aleksandra ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACTH; B endorphin; Opiates naltrexone; Self injuring behavior (SIB); Stress

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; NALTREXONE; PLACEBO; PROOPIOMELANOCORTIN;

ADOLESCENT; ADULT; AGITATION; ARTICLE; AUTOMUTILATION; BEHAVIOR DISORDER; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RESIDENTIAL CARE; RESIDENTIAL HOME;

ADRENOCORTICOTROPIC HORMONE; ADULT; AROUSAL; BETA-ENDORPHIN; CIRCADIAN RHYTHM; COMPUTERS, HANDHELD; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PRO-OPIOMELANOCORTIN; REFERENCE VALUES; SELF-INJURIOUS BEHAVIOR; SOCIAL ENVIRONMENT;

EID: 56849126798     PISSN: 00121630     EISSN: 10982302     Source Type: Journal    
DOI: 10.1002/dev.20323     Document Type: Article

References (72)

1. al'Absi, M., Wittmers, L. E., Ellestad, D., Nordehn, G., Kim, S. W., Kirschbaum, C., & Grant, J. E. (2004). Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade. Psychosomatic Medicine, 66(2), 198-206.
2. Bakeman, R., & Gottman, J. M. (1997). Observing interaction: An introduction to sequential analysis. 2nd edition. Cambridge, UK: Cambridge University Press.
3. Barna, I., Koenig, J. I., & Davis, T. P. (1992). Effects of mediobasal hypothalamic lesion on immunoreactive ACTH/ beta-endorphin levels in cerebrospinal fluid, in discrete brain regions, in plasma and in pituitary of the rat. Brain Research, 593, 69-76.
4. Barron, J. L., & Sandman, C. A. (1983). The relationship of sedative-hypnotic response to self-injurious behavior and stereotypy in mentally retarded clients. American Journal of Mental Deficiency, 88, 177-186.
5. Beckwith, W., Sandman, C. A., Hothersall, D., & Kastin, A. J. (1976). The influence of neonatal injections of a-MSH on learning, memory and attention in rats. Physiology and Behavior, 18, 63-71.
6. Bicknell, A. B., Savva, D., & Lowry, P. J. (1996). Proopiomelanocortin and adrenal function. Endocrine Research, 22, 385-393.
7. Bouvard, M. P., Leboyer, M., Launay, J. M., Recasens, C., Plumet, M. H., Waller-Perotte, D., et al. (1995). Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: A double-blind, placebo-controlled study. Psychiatry Research, 58, 191-201.
8. Breese, G. R., Criswell, H. E., Duncan, G. E., & Mueller, R. A. (1990). A dopamine deficiency model of Lesch-Nyhan disease - The neonatal-6-OHDA-lesioned rat. Brain Research Bulletin, 25, 477-484.
9. Breese, G. R., Knapp, D. J., Criswell, H. E., Moy, S. S., Papadeas, S. T., & Blake, B. L. (2005). The neonate-6-hydroxydopamine-lesioned rat: A model for clinical neuroscience and neurobiological principles. Brain Research Brain Research Reviews, 48(1), 57-73.
10. Cazzullo, A. G., Musetti, M. C., Musetti, L., Bajo, S., Sacerdote, P., & Panerai, A. (1999). Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children. European Neuropsychopharmacology, 9, 361-363.
11. Chamberlain, R. S., & Herman, B. H. (1990). A novel biochemical model linking dysfunctions in brain melatonin, proopiomelan cortin peptides and serotonin in autism. Biological Psychiatry, 28, 773-793.
12. Claes, L., & Vandereycken, W. (2007). Self-injurious behavior: Differential diagnosis and functional differentiation. Comprehensive Psychiatry, 48(2), 137-144.
13. Crain, S. M., & Shen, K. F. (1995). Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proceedings of the National Academy of Sciences of the United States of America, 92, 10540-10544.
14. Crews, W. D., Jr., Rhodes, R. D., Bonaventura, S. H., Rowe, F. B., & Goering, A. M. (1999). Cessation of long-term naltrexone administration: Longitudinal follow-ups. Research in Developmental Disabilities, 20, 23-30.
15. Crockett, C. M., Sackett, G. P., Sandman, C. A., Chicz-DeMet, A., & Bentson, K. L. (2007). Beta-endorphin levels in longtailed and pigtailed macaques vary by abnormal behavior rating and sex. Peptides, 28(10), 1987-1997.
16. Emerson, E., Kiernan, C., Alborz, A., Reeves, D., Mason, H., Swarbrick, R., et al. (2001). Predicting the persistence of severe self-injurious behavior. Research in Developmental Disabilities, 22, 67-75.
17. Ernst, M., Devi, L., Silva, R. R., Gonzalez, M. N., Small, A. M., Malone, R. P., et al. (1993). Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children. Psychopharmacology Bulletin, 29, 221-227.
18. Fisher, W. W., Piazza, C. C., & Roane, H. S. (2002). Sleep and cyclical variables related to self injurious and other destructive behaviors. In: S. R. Schroeder, M. L. Oster-Ganite, & T. Thompson (Eds.), Self injurious behavior: Gene-brain-behavior relationship (pp. 205-221). Washington D.C.: American Psychological Association.
19. Gillberg, C. (1995). Endogenous opioids and opiate antagonists in autism: Brief review of empirical findings and implications for clinicians. Developmental Medicine and Child Neurology, 37, 88-92.
20. Green, A. H. (1967). Self-mutilation in schizophrenic children. Archives of General Psychiatry, 17, 234-244.
21. Hargreaves, K. M., Flores, C. M., Dionne, F. A., & Mueller, G. P. (1990). The role of the pituitary beta-endorphin in mediating corticotropin-releasing factor-induced antinociception. The American Journal of Physiology, 258, 235-242.
22. Hendris, C. A. (1989). Naloxone-sensitive hyperalgesia induced by morphine and environment stimulation. Pharmacology, Biochemistry and Behavior, 32, 961-966.
23. Krivoy, W. A., Kroeger, D. C., & Zimmerman, E. (1977). Neuropeptides: Influence of acute and chronic effects of opiates. Psychoneuroendocrinology, 21, 43-51.
24. Kroeker, R., Touchette, P. E., Engleman, L., & Sandman, C. A. (2004). Quantifying temporal distributions of self-injurious behavior: Defining bouts vs. discrete events. American Journal on Mental Retardation, 109, 1-8.
25. Laatikainen, T., Virtanen, T., Kaaja, R., & Salminen-Lappalainen, K. (1991). Corticotropin releasing hormone in maternal and cord plasma in pre-eclampsia. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 39, 19-24.
26. Leboyer, M., Bouvard, M. P., Recasens, C., Philippe, A., Guilloud-Bataille, M., Bondoux, D., et al. (1994). Difference between plasma N- and C-terminally directed beta-endorphin immunoreactivity in infantile autism. The American Journal of Psychiatry, 151, 1797-1801.
27. Leboyer, M., Philippe, A., Bouvard, M., Guilloud-Bataille, M., Bondoux, D., Tabuteau, F., et al. (1999). Whole blood serotinin and plasma beta-endorphin in autistic probands and their first degree relatives. Biological Psychiatry, 45, 158-163.
28. Lewis, M. H., Bodfish, J. W., Powell, S. B., Parker, D. E., & Golden, R. N. (1996). Clomipramine treatment for self-injurious behavior of individuals with mental retardation: A double-blind comparison with placebo. American Journal of Mental Retardation 100, 654-665.
29. Ludäscher, P., Bohus, M., Lieb, K., Philipsen, A., Jochims, A., & Schmahl, C. (2007). Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder. Psychiatry Research, 149(1-3), 291-296.
30. MacKay, D., McDonald, G., & Morrissey, M. (1974). Self-mutilation in the mentally subnormal. Journal of Psychological Research on Mental Subnormality, 1, 25-30.
31. Mains, R. E., & Eipper, B. A. (1999). Peptides. In: G. J. Siegal, B. W. Agranoff, R. W. Albers, S. K. Fisher, & M. D. Uhler (Eds.), Basic neurochemistry: Molecular, cellular and medical aspects (6th edition, pp. 363-382). 6th edition. Philadelphia: Lipincott Williams & Wilkins Publishers.
32. Marion, S., Touchette, P. E., & Sandman, C. A. (2003). Lag sequential analysis reveals a unique structure for self-injurious behavior. American Journal of Mental Retardation, 108, 301-313.
33. Marion, S. D., Touchette, P. E., Kroeker, R., & Sandman, C. A. (2005). Response to "Self-injury and sequential analysis: Context matters". American Journal on Mental Retardation, 110, 326-329.
34. McGivern, R., Berka, C., Berntson, G. G., Walker, J. M., & Sandman, C. A. (1979). Effect of naloxone on analgesia induced by food deprivation. Life Sciences, 25(10), 885-888.
35. Novak, M. A. (2003). Self-injurious behavior in rhesus monkeys: New insights into its etiology, physiology and treatment. American Journal of Primatology, 59, 3-19.
36. Panksepp, J., Herman, H., Conner, R., Bishop, P., & Scott, J. P. (1978). The biology of social attachments: Opiates alleviate separation distress. Biological Psychiatry, 13, 607-618.
37. Richman, D. M., & Quigg, A., (2004) Emerging Self-Injury in Young Children with Disabilities. Proceedings of the 37th Annual Gatlinburg Conference.
38. Rosenblatt, M. I., & Dickerson, I. M. (1997). Endoproteolysis at tetrabasic amino acid sites in procalcitonin gene-related peptide by pituitary cell lines. Peptides, 18, 567-576.
39. Sandman, C. A. (1990/1991). The opiate hypothesis in autism and self-injury. Journal of Child and Adolescent Psychopharmacology, 1, 235-246.
40. Sandman, C. A., Alexander, W. D., & Kastin, A. J. (1973). Neuroendocrine influences on visual discrimination and reversal learning in the albino and hooded rat. Physiology & Behavior, 11, 613-617.
41. Sandman, C. A., & Barron, J. (1992). Paradoxical response to sedative/ hypnotics in subjects with self-injurious behavior and stereotypy. Journal of Developmental and Physical Disabilities, 4, 4-10.
42. Sandman, C. A., Barron, J. L., Chicz-DeMet, A., & DeMet, E. (1990). Plasma b-endorphin levels in patients with self-injurious behavior and stereotypy. American Journal of Mental Retardation, 95, 3-10.
43. Sandman, C. A., Barron, J. L., DeMet, E., Chicz-DeMet, A., & Rothenburg, S. (1990). Opioid peptides and development: Clinical implications. In: G. F. Koob & C. A. Sandman & F. L. Strand (Eds.), A decade of neuropeptides, past, present and future (pp. 91-107). New York: Annals of the New York Academy of Sciences.
44. Sandman, C. A., & Hetrick, W. P. (1995). Opiate mechanisms in self-injury. Mental Retardation and Developmental Disabilities Research Reviews, 1, 130-136.
45. Sandman, C. A., Hetrick, W. P., Taylor, D. V., Barron, J. L., Touchette, P., Lott, I., et al. (1993). Naltrexone reduces self-injury and improves learning. Experimental and Clinical Psychopharmacology, 1, 242-258.
46. Sandman, C. A., Hetrick, W. P., Taylor, D. V., & Chicz-DeMet, A. (1997). Dissociation of POMC peptides after self-injury predicts response to centrally acting opiate blockers. American Journal of Mental Retardation, 102, 182-199.
47. Sandman, C. A., Hetrick, W., Taylor, D., Marion, S., & Chicz-DeMet, A. (2000a). Uncoupling of proopiomelanocortin (POMC) fragments is related to self-injury. Peptides, 21, 785-791.
48. Sandman, C. A., Hetrick, W. P., Taylor, D. V., Marion, S., Touchette, P., Barron, J. L., Martinazai, V., Steinberg, R., & Crinella, F. M. (2000b). Long-term effects of naltrexone on self-injurious behavior. American Journal of Mental Retardation, 105, 103-117.
49. Sandman, C. A., & Kastin, A. J. (1981). The influence of fragments of the LPH chain on learning, memory and attention in animals and man. Pharmacology and Therapeutics, 13, 39-60.
50. Sandman, C. A., & Kastin, A. J. (1990). Neuropeptide modulation of development and behavior: Implications for psychopathology. In: S. Deutsch (Ed.), Application of basic neuroscience to child psychiatry (pp. 101-124). Washington D.C.: Plenum Publishing.
51. Sandman, C. A., Miller, L. H., Kastin, A. J., & Schally, A. V. (1972). Neuroendocrine influence on attention and memory. Journal of Comparative Physiology & Psychology, 80, 54-58.
52. Sandman, C. A., Spence, M. A., & Smith, M. (1999). Proopiomelanocortin (POMC) disregulation and response to opiate blockers. Mental Retardation and Developmental Disabilities Research Reviews, 5, 314-321.
53. Sandman, C. A., Thompson, T., Barrett, R. P., Verhoeven, W. M. A., McCubbin, J. A., Schroeder, S. R., & Hetrick, W. P. (1998). Opiate blockers. In: M. Aman & S. Reiss (Eds.), Consensus Handbook on Psychopharmacology (pp. 291-302). Columbus, Ohio: Ohio State University.
54. Sandman, C. A., & Touchette, P. (2001). Opioids and the maintenance of self-injurious behavior. In: S. R. Schroeder, M. L. Oster-Granite, & T. Thompson (Eds.), Self injurious behavior: Gene-brain-behavior relationships (pp. 191-204). Washington DC: American Psychological Association.
55. Sandman, C. A., Touchette, P., Lenjavi, M., Marion, S., & Chicz-DeMet, A. (2003). B-Endorphin and ACTH are dissociated after self-injury in adults with developmental disabilities. American Journal on Mental Retardation, 108, 414-424.
56. Sandman, C. A., Touchette, P., Ly, J., Marion, S., & Bruinsma, Y. (2000c). Computerized-assessment of treatment effects among individuals with developmental disabilities. In: T. Thompson, D. Felces, & F. Symons (Eds.), Behavioral observations: technology and applications in developmental disabilities (pp. 271-293). Baltimore: Brookes Publishing Co.
57. Sandman, C. A., Touchette, P., Marion, S., Lenjavi, M., & Chicz-DeMet, A. (2002). Disregulation of proopiomelanocortin and contagious maladaptive behavior. Regulatory Peptides, 108, 179-185.
58. Sasaki, A., Sato, S., Murakami, O., Go, M., Inoue, M., Shimizu, Y., et al. (1987). Immunoreactive corticotropin-releasing hormone present in human plasma may be derived from both hypothalamic and extrahypothalamic sources. Journal of Clinical Endocrinology & Metabolism, 65, 176-182.
59. Schaefer, G. J., & Michael, R. P. (1990). Interactions of naloxone with morphine, amphetatine and phencyclide on fixed interval responding for intracranial self-stimulation in rats. Psychopharmacology, 102, 263-268.
60. Schroeder, S. R., Oster-Granite, M. L., & Thompson, T. (2002). Self-injurious behavior: Gene-brain-behavior relationships. Washington D.C.: American Psychological Association.
61. Schroeder, S. R., Rojahn, J., & Mulick, J. A. (1978). Ecobehavioral organization of developmental day care for the chronically self-injurious. Journal of Pediatric Psychology, 3, 81-88.
62. Seidah, N. G., & Chretien, M. (1992). Propreotein and prohormone convertases of the subtilisin family. Trends in Endocrinology and Metabolism, 3, 133-140.
63. Seidah, N. G., Marcinkiewicz, M., Benjannet, S., Gaspar, L., Beaubien, G., Mattei, M. G., et al. (1991). Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, Furin, and KEX 2: Distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2. Molecular Endocrinology, 5, 111-122.
64. Shen, K. F., & Crain, S. M. (1992). Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance. Brain Research, 597, 74-83.
65. Shishido, T., Watanabe, Y., Kato, K., Horikoshi, R., & Niwa, S. (2000). Effects of dopamine, NMDA, opiate, and serotonin-related agents on acute methamphetamine-induced self-injurious behavior in mice. Pharmacology, Biochemistry and Behavior, 66, 579-583.
66. Strand, F. L. (1999). Neuropeptides: Regulators of physiological processes. Cambridge, MA: MIT Press.
67. Szekely, J., Miglecz, E., Dunai-Kovacs, Z., Tarnawa, I., Ronai, A. Z., Graf, L., & Bajusz, S. (1979). Attenuation of morphine tolerance and dependence by α-melanocyte stimulating hormone. Life Sciences, 24, 1931-1938.
68. Thompson, T., Hackenberg, T., Cerutti, D., Baker, D., & Axtell, S. (1994). Opioid antagonist effects on self-injury in adults with mental retardation: Response form and location as determinants of mediation effect. American Journal of Mental Retardation, 99, 85-102.
69. Tiefenbacher, S., Novak, M. A., Jorgensen, M. J., & Meyer, J. S. (2000). Physiological correlates of self-injurious behavior in captive, socially-reared rhesus monkeys. Psychoneuroendocrinology, 25, 799-817.
70. White, T., & Schultz, S. K. (2000). Naltrexone treatment for a 3-year-old boy with self-injurious behavior. The American Journal of Psychiatry, 157, 1574-1582.
71. Willemsen-Swinkels, S. H., Buitelaar, J. K., van Berchelaer-Onnes, I., & van Engeland, H. (1999). Brief-report: Six months continuation treatment in naltrexone-responsive children with autism: An open-label case-control design. Journal of Autism Developmental Disorders, 29, 167-169.
72. Zheng, M., Streck, R. D., Scott, R. E. M., Seidah, N. J., & Pintar, J. E. (1994). The developmental expression in rat of proteases furin, PC1, PC2, and carboxypeptidase E: Implications for early maturation of proteolytic processing capacity. Journal of Neuroscience, 14, 4656-4673.